This study examines the effect of Depakote ER versus placebo in a randomized trial of
borderline personality disorder. Patients all participate in DBT therapy and those who are
not responsive are assigned to either Depakote ER or placebo for up to 12 weeks. Borderline
Personality Symtoms are measured and side-effects are assessed.
Phase:
N/A
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute